ZOLI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 4.224
AS - Asia 3.024
EU - Europa 1.337
SA - Sud America 582
AF - Africa 95
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.315
Nazione #
US - Stati Uniti d'America 4.095
SG - Singapore 1.031
CN - Cina 825
BR - Brasile 462
IT - Italia 458
VN - Vietnam 331
HK - Hong Kong 276
DE - Germania 189
TR - Turchia 180
UA - Ucraina 140
GB - Regno Unito 119
FR - Francia 89
RU - Federazione Russa 81
IN - India 71
MX - Messico 59
ID - Indonesia 54
CA - Canada 53
FI - Finlandia 51
AU - Australia 49
PL - Polonia 47
BD - Bangladesh 45
AR - Argentina 43
JP - Giappone 39
NL - Olanda 38
ZA - Sudafrica 38
IQ - Iraq 25
SE - Svezia 24
ES - Italia 21
EC - Ecuador 20
IR - Iran 19
PH - Filippine 17
MA - Marocco 15
CO - Colombia 14
PK - Pakistan 13
MY - Malesia 12
UZ - Uzbekistan 12
VE - Venezuela 12
AT - Austria 11
CZ - Repubblica Ceca 11
LT - Lituania 11
PY - Paraguay 11
CL - Cile 10
NG - Nigeria 10
SA - Arabia Saudita 10
IE - Irlanda 9
TW - Taiwan 9
EG - Egitto 7
JO - Giordania 7
GR - Grecia 6
TN - Tunisia 6
CH - Svizzera 5
HU - Ungheria 5
KE - Kenya 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
KG - Kirghizistan 4
LB - Libano 4
NI - Nicaragua 4
PE - Perù 4
RS - Serbia 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
BO - Bolivia 3
HN - Honduras 3
KR - Corea 3
NP - Nepal 3
PS - Palestinian Territory 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
ET - Etiopia 2
GE - Georgia 2
KH - Cambogia 2
LY - Libia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
BG - Bulgaria 1
BJ - Benin 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
OM - Oman 1
Totale 9.310
Città #
Ashburn 716
Singapore 674
Fairfield 479
Santa Clara 337
Hong Kong 272
San Jose 262
Beijing 258
Woodbridge 211
Seattle 198
Wilmington 168
Cambridge 158
Izmir 157
Houston 155
Ho Chi Minh City 133
Nanjing 78
New York 70
Princeton 69
Lauterbourg 68
Hanoi 67
Ann Arbor 63
Dallas 60
Los Angeles 57
Jacksonville 56
Munich 54
São Paulo 52
Council Bluffs 50
Milan 44
Mexico City 42
Boardman 41
Warsaw 40
Bologna 36
Jakarta 34
Helsinki 33
Rome 33
London 32
Shanghai 32
Tokyo 32
San Diego 27
Shenyang 26
Ferrara 25
Sydney 25
Chandler 23
Chicago 21
Bremen 20
Florence 18
Nanchang 18
Tianjin 18
Hebei 17
Jinan 17
Brooklyn 16
Montreal 16
Orem 16
Guangzhou 15
Johannesburg 15
Turku 15
Frankfurt am Main 14
Rio de Janeiro 14
Belo Horizonte 13
Changsha 13
Chennai 13
Haiphong 13
Imola 13
Jiaxing 13
Toronto 13
Turin 13
Atlanta 12
Baghdad 12
Da Nang 12
Denver 12
Melbourne 12
Norwalk 12
Stockholm 11
Istanbul 10
Modena 10
Moscow 10
Nuremberg 10
Palermo 10
Buffalo 9
Falls Church 9
Mumbai 9
Ottawa 9
Porto Alegre 9
San Francisco 9
Brasília 8
Brno 8
Bắc Ninh 8
Fortaleza 8
Manchester 8
Mountain View 8
Quito 8
Reggio Nell'emilia 8
Taizhou 8
Verona 8
Zhengzhou 8
Amsterdam 7
Augusta 7
Carapicuíba 7
Dhaka 7
Falkenstein 7
Hefei 7
Totale 6.118
Nome #
Effects of Ethanol on the Digestive System: A Narrative Review 354
Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi [Sindrome di Budd-Chiari a decorso fatale in paziente con policitemia vera e sindrome da anticorpi antifosfolipidi] 272
Alcohol Hub: il trattamento farmacologico dei disordini da uso di alcol 242
Sindrome da astinenza protratta da alcol: il ruolo del sodio ossibato...e non solo 200
Splenic autotransplantation after splenectomy: Tuftsin activity correlates with residual splenic function 194
A brief up-date of the use of sodium oxybate for the treatment of alcohol use disorder 190
Randomised controlled trial of mesalazine in IBS 187
Osteoporosis in Celiac Disease: An Update 181
Nutritional Treatment in Crohn’s Disease 168
Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options 166
Beyond biologics: advanced therapies in inflammatory bowel diseases 165
Effect of gluten-free diet on gut microbiota composition in patients with celiac disease and non-celiac gluten/wheat sensitivity 160
Cardiac involvement in Crohn's disease: Echocardiographic study 159
A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse 159
Alcohol use disorder in the COVID-19 era: Position paper of the Italian Society on Alcohol (SIA) 158
Alcohol use in patients with chronic liver disease 157
Alcohol use disorder and GABAB receptor gene polymorphisms in an Italian sample: haplotype frequencies, linkage disequilibrium and association studies 155
A reassessment of splenic hypofunction in celiac disease 146
An evaluation of factors affecting helicobacter pylori prevalence in tibetans exiled in india 146
The course of inflammatory bowel disease during pregnancy and postpartum: A prospective European ECCO-EpiCom Study of 209 pregnant women 145
Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau 144
Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA) 140
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity 137
Alcohol use disorders and liver fibrosis: an update 136
Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition 136
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE) 135
Life-threatening onset of coeliac disease: A case report and literature review 133
Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series 132
Evidence-based decision for pharmacological management of alcoholic liver disease and alcohol dependence 131
Prevalence of celiac disease in inflammatory bowel diseases: An IG-IBD multicentre study 127
Recurrent myocarditis in a patient with active ulcerative colitis: A case report and review of the literature 123
Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: A review 122
Treatment of alcohol-use disorders 120
Impact of Female Gender in Inflammatory Bowel Diseases: A Narrative Review 119
A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease 118
Plasma Norepinephrine, Weak Neurotransmitters, and Renin Activity During Active Tilting in Liver Cirrhosis: Relationship with Cardiovascular Homeostasis and Renal Function 117
Treatment of narcolepsy with cataplexy 116
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence 116
Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study 116
Gastrointestinal involvement in anderson-fabry disease: A narrative review 115
Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls 114
Promotion of gallbladder emptying by intravenous aminoacids 113
Subclinical coeliac disease: an anthropometric assessment 113
Cytophilic antibodies cause leucocyte migration inhibition in coeliac disease 112
CLINICAL APPLICATIONS OF SCANNING ELECTRON MICROSCOPY IN GASTROINTESTINAL DISEASES 111
Changes in peripheral blood lymphocytes and immune complexes in splenectomized patients: lack of correlation with residual splenic function 110
Increased resting lipid oxidation in Crohn's disease 108
Defective phagocyte activity in adult coeliac disease 107
Efficacy and safety of capsule endoscopy in octogenarian patients: a retrospective study 105
Therapeutic options for coeliac disease: What else beyond gluten-free diet? 105
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 102
Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study 102
Gamma hydroxybutyric acid (GHB): A valid pharmacological opportunity for the treatment of alcohol dependence 100
Alcohol Use in Adults Reply 94
Increased energy expenditure in growing adolescents with Crohn's disease 92
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 89
Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy 87
Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: Partial benefit by infiximab - A pilot study 87
Echocardiographic evaluation of anti-Tumor Necrosis Factor-α therapy with infliximab in patients without cardiac pathologies 86
Major gastrointestinal hemorrhage during anticoagulant therapy in patients with atrial fibrillation: When should treatment be resumed? [Emorragia gastrointestinale maggiore in corso di terapia anticoagulante nei pazienti con fibrillazione atriale: quando riprendere il trattamento? ] 85
Effect of arginine thiazolidinecarboxylate (ATCA)* * SULFILE is the trade name for arginine thiazolidinecarboxylate (200 mg vials) manufactured by Poli-Industria Chimica, Italy. on some clinical and functional parameters in cirrhotic patients 83
Identification of harmful drinking in subjects who have had their driving license suspended due to alcohol use: a retrospective Italian study 83
Symptoms of protracted alcohol withdrawal in patients with alcohol use disorder: a comprehensive systematic review 81
Tuftsin deficiency in AIDS 77
Il trattamento farmacologico della dipendenza da alcol 77
S.E.M. study I: Gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs (aspirin, piroxicam) in man 73
Ocular naevus and hyperaemia with dilation of the conjunctival vessels: An early manifestation of Crohn's disease? 73
Ultrastructural aspects of duodenal mucosa repair during treatment of peptic disease 72
Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study 72
Efficacy and safety of gamma-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: A case report 72
S.E.M. study II. Protective effect of ranitidine against gastric and duodenal lesions induced by non-steroidal anti-inflammatory drugs 71
Failure of adrenergic system in the control of arterial pressure in cirrhosis. Role of weak neurotransmitters 70
Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial 66
Howell‐Jolly body counting as a measure of splenic function. A reassessment 66
Pseudothrombocytopenia clinical comment on 37 cases 65
Famotidine and ranitidine in the prevention of duodenal ulcer 62
The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder 61
Totale 9.483
Categoria #
all - tutte 53.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.386
Totale 55.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 76 54 29
2021/2022404 22 33 4 24 10 30 24 34 16 73 18 116
2022/2023267 73 9 20 4 26 15 18 15 36 1 34 16
2023/2024387 10 19 10 18 26 15 6 15 10 17 44 197
2024/20251.774 57 92 170 97 210 207 37 68 185 321 172 158
2025/20264.350 372 223 464 663 702 266 466 318 392 484 0 0
Totale 9.483